目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Key Highlights

Chapter- 3: Market and Technology Background
Benefits
The Human Microbiome
Microbiome Therapeutics

Chapter- 4: Market Breakdown by Type of Therapeutic
Introduction
Market Overview
Additive Microbiome Therapeutics
Modulatory Microbiome Therapeutics
Subtractive Microbiome Therapeutics

Chapter- 5: Market Breakdown by Application
Introduction
Infections
Gastrointestinal (GIT) Diseases
Metabolic Diseases
Cancer
Gut-Brain Axis Diseases
Other Diseases
Regional Markets Globally

Chapter- 6: Industry Structure
Investment in Microbiome Therapeutics
Collaborations and Partnerships
Licensing and Manufacturing Agreements
Mergers and Acquisitions
Leading Market Players in the Market for Microbiome Therapeutics
BCC Research Select Insights from Industry Leaders

Chapter- 7: Patent Analysis
Patent Analysis

Chapter- 8: Clinical Trials
Clinical Trials by Disease Category
Clinical Trials by Type of Therapeutic
Clinical Trials by Company

Chapter- 9: Analysis of Market Opportunities
SWOT Analysis

Chapter- 10: Company Profiles
4D PHARMA
AO BIOME LLC
ASSEMBLY BIOSCIENCES INC.
ARMATA PHARMACEUTICALS
AZITRA INC.
BIOMICA
BIOMX
CHAIN BIOTECHNOLOGY LTD.
ELIGO BIOSCIENCE SAS
ENTEROME SA
EVELO BIOSCIENCES
FINCH THERAPEUTICS GROUP INC.
INTRALYTIX INC.
MAAT PHARMA
OSEL INC.
PYLUM BIOSCIENCES INC.
QUORUM INNOVATIONS LLC
REBIOTIX INC. (A FERRING COMPANY)
SECOND GENOME
SENDA BIOSCIENCES INC.
SERES THERAPEUTICS INC.
SFA THERAPEUTICS INC.
SYNLOGIC
THERIVA BIOLOGICS INC.
VEDANTA BIOSCIENCES INC.
YSOPIA BIOSCIENCE INC.

Chapter- 11: Appendix: Acronyms
Table 75 : Acronyms Used in This Report